PROGRAMME

Postgraduate Course

Thursday, September 5, 2019

​​“Microbiota: from metabolism to immunity and fecal microbial transplantation-pearls for the clinician”

Course directors: Antonio Gasbarrini, Herbert Tilg

Opening session:

State-of-the art lectures

Chair:

Antonio Gasbarrini, Herbert Tilg

08.00 - 09.35 hrs

08.00 - 08.05

Welcome

Herbert Tilg, Innsbruck, Austria

Antonio Gasbarrini, Rome, Italy

08.05 - 08.35

What is a healthy microbiome?

Julian Marchesi, London, United Kingdom

 

08.35 - 09.05

The gut microbiota as major player in metabolic disorders

Fredrik Bäckhed, Gothenburg, Sweden

 

09.05 - 09.35

Microbiota-driven personalized medicine: close to reality?

Eran Elinav, Rehovot, Israel

Coffee Break

09.35 - 10.05 hrs

The gut microbiota as complex ecosystem:

from “big data” to clinical reality

Chair: Georgina Hold, Marcis Leja

10.05 - 11.45 hrs

Inflammatory bowel disorders (IBD) and intestinal microbiota

Chair:

Patrizia Kump, Lars Engstrand

13.00 - 14.40 hrs

10.05 - 10.30

Microbiota signatures for various diseases: are we there yet?

Lars Engstrand, Stockholm, Sweden

10.30 - 10.55

What can be learn from population-based microbiota studies

Marie Joossens, Leuven, Belgium

10.55 - 11.20

Gut epithelial barrier dysfunction and evidence for a circulating microbiome

Remy Burcelin, Toulouse, France

11.20 - 11.45

Antibiotics: not only detrimental for the microbiota

Gianluca Ianiro, Rome, Italy

Lunch Break

11.45 - 13.00 hrs

13.00 - 13.25
Gut microbiota composition and IBD: what have we learned?

Harry Sokol, Paris, France

13.25 - 13.50
Pro- and prebiotics in IBD

Alessandro Armuzzi, Rome, Italy

13.50 - 14.15
Biomarkers associated with FMT outcomes

Nadeem Kaakoush, Syndey, Australia

14.15 - 14.40
Faecal microbial transplantation (FMT) and IBD

Patrizia Kump, Graz, Austria

Coffee Break

14.40 - 15.15 hrs

FMT: solution for many disorders?

Chair:

Juozas Kupcinskas, Colm O'Morain

15.15 - 16.55 hrs

15.15 - 15.40
FMT for Clostridium difficile and other antibiotics-resistant bacteria

Giovanni Cammarota, Rome, Italy

15.40 - 16.05
FMT for metabolic syndrome, obesity and diabetes

Max Nieuwdorp, Amsterdam, The Netherlands

16.05 - 16.30
FMT: a role in cancer immunotherapy?

Patricia Lepage, Jouy-en-Josas, France

16.30 - 16.55
FMT in chronic liver diseases and complications

Jasmohan S. Bajaj, Richmond, VA, USA

Closing

16.55 - 17.00 hrs

EHMSG Far East Symposium

Omics for Helicobacter

17.00 - 18.30 hrs

 

Chairs: Sang Woo Lee, Francis Mégraud, Kentaro Sugano

Dynamics of H. pylori genome and methylome variation during early and chronic infection

Sebastian Suerbaum, Munich, Germany

 

Current knowledge of genomics for H. pylori from Far East

Yoshio Yamaoka, Oita, Japan

 

Dynamics of microbial communities in the human stomach and a humanized gastric microbiota mouse model

Soon-Kyeong Kwon, Gyeongsang, South Korea

EHMSG 2019

Welcome Reception

18.30 - 19.30 hrs

EHMSG Core Agency

Vienna Medical Academy

Alser Strasse 4, 1090 Vienna, Austria

Contact

Tel.: +43 1 405 13 83 18

Fax: +43 1 405 13 83 918

© 2019

EHMSG c/o VMA

The EHMSG is a member of the United European Gastroenterology, a professional non-profit organisation combining all the leading European societies concerned with digestive disease.
UEG represents over 22,000 specialists, working across medicine, surgery, paediatrics, GI oncology and endoscopy. This makes UEG the most comprehensive organisation of its kind in the world, and a unique platform for collaboration and the exchange of knowledge.